Search

everythinglearnresearchcommunity

for

Search:↓

The user shared progress pictures after using minoxidil and finasteride for three months, reporting hair stabilization and thickening. They used Amazon's brand for minoxidil and Good Rx for finasteride.

The user has been using a hair solution with 0.3% finasteride and 5% minoxidil, along with microneedling, but is experiencing more thinning on one side. Suggestions include checking application techniques and ensuring microneedling is not overdone.

A user is advocating for Phase 3 trials of the hair loss treatment PP405 to be conducted in Germany, citing benefits like a diverse patient base and faster access for European patients. Despite skepticism about the petition's influence, the user believes it can demonstrate significant interest and potentially influence strategic decisions.

User "logart89" claims DUT 3 times a week is better than daily FIN for hair loss. Their routine includes DUT, topical DUT, stemoxydine and alfatradiol mix, 5% minoxidil with tretinoin, and weekly derma stamping.

User 3 months post hair transplant, using minoxidil and dutasteride. Users discuss possible reasons for odd-looking hair strands.

The user has been using oral finasteride and topical minoxidil for three years, seeing some regrowth initially but mostly maintenance afterward. Suggestions for further improvement include trying dutasteride, RU58841, or a hair transplant.

The user started using finasteride and minoxidil in October 2025 and noticed hair growth and thickening after three months, despite initial concerns about side effects. They are hopeful for continued progress and grateful for the support from the forum community.

12 companies having drugs or therapies in clinical trials during 2023, with various molecules and phases of trial; the probability that some may fail; and progress being made in the field.

Amplifica is testing a compound called AMP-303 for hair loss, but it's not Scube3 or osteopontin. The timing for the results from the clinical trial is unknown.

A user shared their 6-month update on hair loss treatment, using daily Dutasteride, oral and topical Minoxidil, Ketoconazole shampoo, topical Finasteride, dermastamping, and PRP treatments. They reported improved hair quality but no significant regrowth or density increase, and plan to continue the regimen for another year before considering a hair transplant.

User shared 9-month hair regrowth progress using a Fin/Min spray from HIMS, with additional microneedling. Other users praised the results and discussed the effectiveness of topical treatments.

User experienced hair loss from Norwood 3.5 to Norwood 5 with diffuse thinning after using a hair system for 2 years. Tried Redensyl, Capixyl, Bicapil, Biotin, multivitamins, Fin, and Min without significant improvement, seeking advice for hair recovery.

The user is 4 months into using a treatment with 5mg Dutasteride and 1.25mg Minoxidil daily, along with vitamin K2 and weekly dermastamping. They report some hairline improvement but no noticeable change in the crown area yet.

The conversation discusses recommendations for Vitamin D3 supplements for hair health. Specific treatments mentioned include Minoxidil, finasteride, and RU58841.

The post and conversation discuss the unpredictable nature of diffuse thinning, a type of hair loss. Users share personal experiences, with some mentioning treatments like oral finasteride and toppik, and the need for patience with these treatments.

The user experienced significant hair improvement after three months using topical Minoxidil and scalp massages. They are considering adding Finasteride to their regimen.

The FDA policy change may speed up approval for hair loss drugs like PP405, VDPHL-01, and Breezula by potentially eliminating the need for a second confirmatory Phase 3 trial. Approval timelines could be as early as 2028 for some treatments if Phase 3 results are strong.

The user's hair appears to have improved, looking thicker and healthier, especially around the temples, after using topical minoxidil, finasteride, dutasteride, and tretinoin. Most participants agree the last picture shows significant improvement, though one disagrees.

A 32-year-old is documenting their 3-month progress in treating hair loss using 0.5 mg dutasteride, topical and 5 mg oral minoxidil, and Ducray Anaphase+ shampoo daily. They report slight libido reduction and increased eyebrow hair but are generally satisfied with the results and considering a hair transplant after a year.

The "Big 3 Stack" for hair loss treatment, which includes Minoxidil for hair density improvement, Ketoconazole shampoo for enhancing hair volume and thickness, and Finasteride for blocking hair loss causing hormones. Microneedling can boost Minoxidil's effects.

3 months of progress with Finasteride and Minoxidil treatment for hair loss, as well as Nutrafol vitamins and low-level light therapy. The user experienced no problems and had a satisfied girlfriend to boot!

The user has been using finasteride, dutasteride, minoxidil, and RU58841 for hair loss but is experiencing worsening hair density despite treatment. They are frustrated and confused as their hairline remains unchanged, but the overall hair thickness has decreased significantly.

A phase 3 trial for Breezula (clascoterone solution) to treat male pattern hair loss has been listed, with 726 participants and a completion date of January 2025. Other treatments mentioned include Aneira Pharma's combination of minoxidil and latanoprost, Triple Hair's combination of minoxidil, latanoprost, and finasteride, and a new microneedling and LLLT device called StimuSIL.

A user is treating their advanced hair loss with a regimen including topical finasteride, minoxidil, hydrocortisone, stem cell serum, peptide serum, multivitamins, he shou wu tea, derma pen, argan oil, and a derma roller. Replies suggest it's too early to judge progress and recommend staying consistent, with one suggesting oral minoxidil as an additional option.

Clascoterone solution is in Phase III trials for male androgenetic alopecia, with results expected in the second half of 2025. Commercialization is anticipated in about 2-3 years, but there are concerns about delays and market expectations.

The user is experiencing hair thinning despite using Dutasteride and Finasteride and is considering adding Minoxidil. Suggestions include increasing the Dutasteride dose, checking for health issues, and considering a hair transplant.

After a hair transplant, the user is concerned about not seeing new hair growth at 3 months, despite using dutasteride and minoxidil. It is advised to continue the treatment as new hair typically starts growing around 4 to 6 months post-surgery.

A user shared progress pictures showing significant hair regrowth after 3 months using a topical foam with 5% Minoxidil and 0.25% Finasteride. They plan to add derma rolling to their routine.

GT20029 is a topical treatment that degrades androgen receptors to prevent hair thinning and loss, potentially offering fewer side effects than systemic treatments like finasteride. Concerns include its impact on hair texture and potential systemic effects, with market availability speculated in 3 to 5 years.

Several new hair loss treatments are in development, with Cosmo Breezula and Kintor KX826 being the furthest along, expected to be commercialized by 2027. Veradermics is the only treatment in pill form, while others like KX/GT/Breezula will be topical.